MedTrace Logo

Assess the Efficacy and Safety of Rhinocort Aqua

NCT00641693 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 650

Last updated 2011-01-24

No results posted yet for this study

Summary

The purpose of this study is to compare Rhinocort with placebo in pediatric subjects aged 2-5 years with allergic rhinitis to study effects on nasal symptoms such as sneezing, runny and stuffy noses.

Conditions

  • Allergic Rhinitis

Interventions

DRUG

Budesonide

16mg Nasal Spray

DRUG

Budesonide

32mg Nasal Spray

DRUG

Budesonide

64mg Nasal Spray

DRUG

Placebo

Sponsors & Collaborators

Principal Investigators

  • Liza O'Dowd, MD · AstraZeneca

  • Bertil Andersson · AstraZeneca

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Primary Completion
2005-05-31
Completion
2005-05-31

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00641693 on ClinicalTrials.gov